The five-day program brought together 54 professionals from industry and academia to bridge the gap between established flow cytometry infrastructure and emerging functional analysis. By running Nanovial workflows on imaging-enabled and large-particle sorters, attendees explored a method for screening live cells based on their behavioral outputs rather than static molecular indicators.

Yoav Altman, the course organizer, noted that integrating Nanovials allows facilities to maximize their current hardware for complex tasks like TCR discovery. This compatibility serves as a key strategy for Partillion Bioscience, as the company seeks to lower capital barriers for labs looking to expand their research capabilities. Following successful training sessions at both this event and the earlier Cell-Cell Symposium at UCLA, CEO Joe de Rutte emphasized that equipping core facility experts creates a multiplier effect, enabling individual labs to adopt these protocols for routine use.